ABC | Volume 110, Nº4, Abril 2018

Artigo Original Muñoz et al Ablação da fibrilação atrial na doença valvar Arq Bras Cardiol. 2018; 110(4):312-320 1. Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, et al. The registry of the German competence NETwork on atrial fibrillation: patient characteristics and initial management. Europace. 2009;11(4):423-34. doi: 10.1093/europace/eun369. 2. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al; ESC Committee for Practice Guidelines. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360- 420. doi: 10.1093/europace/euq350. Erratum in: Europace. 2011 Jul;13(7):1058. 3. HalkosME, Craver JM, Thourani VH, Kerendi F, Puskas JD, CooperWA, et al. Intraoperative radiofrequency ablation of the treatment of atrial fibrillation during concomitant cardiac surgery. Ann Thorac Surg. 2005;80(1):210-5. doi: 10.1016/j.athoracsur.2005.01.051. 4. Feyrer R, Ballazhi F, Seitz T,WeyandM, Harig F. Impact of medical treatment on long-term results after surgical ablation of atrial fibrillation in cardiac surgical patients. Ann Thorac Cardiovasc Surg. 2014;20(3):207-12. doi: 10.5761/atcs.oa.12.02233. 5. GrohMA, Binns OA, BurtonHG3 rd , Ely SW, Johnson AM. Ultrasonic cardiac ablation for atrial fibrillation during concomitant cardiac surgery: long-term clinical outcomes. Ann Thorac Surg. 2007;84(6):1978-83. doi: 10.1016/j. athoracsur.2007.06.081. 6. To AC, Flamm SD, Marwick TH, Klein AL. Clinical utility of multimodality LA imaging: assessment of size, function, and structure. JACC Cardiovasc Imaging. 2011;4(7):788-98. doi: 10.1016/j.jcmg.2011.02.018. 7. Myrdko T, Sniezek-Maciejewska M, Rudzinski P, Myc J, Lelakowski J, Majewski J. Efficacy of intra-operative radiofrequency ablation in patients with permanent atrial fibrillation undergoing concomitant mitral valve replacement. Kardiol Pol. 2008;66(9):932-8. PMID: 18924020. 8. GillinovAM, BlackstoneEH,McCarthyPM.Atrial fibrillation:currentsurgical options and their assessment. Ann Thorac Surg. 2002;74(6):2210-7. doi: https://doi.org/10.1016/S0003-4975 (02)03977-2. 9. Reyes G, Benedicto A, Bustamante J, Sarraj A, Nuche JM, Alvarez P, et al. Restoration of atrial contractility after surgical cryoablation: clinical, electrical andmechanical results. Interact Cardiovasc Thorac Surg 2009;9(4):609-12. doi: 10.1510/icvts.2009.208173. 10. Lang RM, Bierig M, Devereux RB, Flachskamp FA, Foster E, Pellikka PA, et al; Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J AmSoc Echocardiogr. 2005;18(12):1440-63. doi: 10.1016/j.echo.2005.10.005. 11. Evangelista A, Flachskampf F, Lancellotti P, Badanao L, Aguilar R, Monaghan M, et al; European Association of Echocardiography. European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr. 2008;9(4):438-48. doi: 10.1093/ejechocard/jen174. 12. Aguilar-Torres R. Assesment of left atrial function. In: The EAE textbook of echocardiography. Oxford: European Society of Cardiology;/Oxford University Press; 2011. p.151-64. 13. Prieto L, Lamarca R, Casado A. [Assessment of the reliability of clinical findings: the intraclass correlation coefficient]. Med Clin (Barc). 1998;110(4):142-5. PMID: 9541905. 14. Veasey RA, Segal OR, Large JK, Lewis ME, Trivedi UH, Cohen AS, et al. The efficacy of intraoperative atrial radiofrequency ablation for atrial fibrillation during concomitant cardiac surgery-the Surgical Atrial Fibrillation Suppression (SAFS) Study. J Interv Card Electrophysiol. 2011;32(1):29-35. doi: 10.1007/s10840-011-9576-y. 15. Gaynor SL, Diodato MD, Prasad SM, Ishii Y, Schuessler RB, Bailey MS, et al. A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg. 2004;128(4):535-42. doi: 10.1016/j.jtcvs.2004.02.044. Erratum in: J Thorac Cardiovasc Surg. 2006;131(4):772. 16. Budera P, Straka Z, Osmančík P, Van ě k T, Jelínek Š, Hlavička J, et al. Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgerywithout atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study. Eur Heart J. 2012;33(21):2644-52. doi: 10.1093/ eurheartj/ehs290. 17. BeukemaWP, Sie HT, Misier AR, Delnoy PP, Wellens HJ, Elvan A. Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure. Eur J Cardiothorac Surg. 2008;34(4):771-5. doi: 10.1016/j.ejcts.2008.07.026. 18. Vieira MJ, Teixeira R, Gonçalves L, Gersh BJ. Left atrial mechanics: echocardiographic assessment and clinical implications. J Am Soc Echocardiogr. 2014;27(5):463-78. doi: 10.1016/j.echo.2014.01.021. 19. Candan O, Ozdemir N, Aung SM, Dogan C, Karabay CY, Gecmen C, et al. Left atrial longitudinal strain parameters predict postoperative persistent atrial fibrillation following mitral valve surgery: a speckle tracking echocardiography study. Echocardiography. 2013;30(9):1061-8. doi: 10.1111/echo.12222. 20. Williams MR, Steward JR, Bolling SF, Freeman S, Anderson JT, Argenziano M, et al. Surgical treatment of atrial fibrillation using radiofrequency energy. Ann Thorac Surg. 2001;71(6):1939-43. doi :http://dx.doi.org/10.1016/ S0003-4975(01)02594-2 21. SchopkaS,SchmidC,KeyserA,KortnerA,Tafelmeier J,DiezC,etal.Ablation of atrial fibrillationwith the Epicor system: a prospective observational trial to evaluate safety and efficacy and predictors of success. J Cardiothorac Surg. 2010 May 5;5:34. doi: 10.1186/1749-8090-5-34. 22. Kourliouros A, Savelieva I, Kiotsekoglou A, Jahangiri M, Camm J. Current concepts in the pathogenesis of atrial fibrillation. Am Heart J. 2009;157(2):243-52. doi: 10.1016/j.ahj.2008.10.009. 23. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation. 2000;101(22):2612-7. doi: https://doi.org/10.1161/01. CIR.101.22.2612. 24. Tayebjee MH, Creta A, Moder S, Hunter RJ, Earley MJ, Dhinoja MB, et al. Impactofangiotensin-convertingenzyme-inhibitorsandangiotensinreceptor blockers on long-term outcome of catheter ablation for atrial fibrillation. Europace. 2010;12(11):1537-42. doi: 10.1093/europace/euq284. 25. AdN, Suri RM, Gammie JS, Sheng S, O’Brien SM, Henry L. Surgical ablation of atrial fibrillation trends and outcomes in North America. J Thorac Cardiovasc Surg. 2012;144(5):1051-60. doi: 10.1016/j.jtcvs.2012.07.065. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 320